Stereotype threat and social function in opioid substitution therapy patients

Author(s): Henry JD, von Hippel C, Terrett G, Mercuri K, McAlear K, et al.

Abstract

Objectives

People with a history of substance abuse are subject to widespread stigmatization. It seems likely that this societal disapproval will result in feelings of stereotype threat, or the belief that one is the target of demeaning stereotypes. If so, stereotype threat has the potential to contribute to functional difficulties including poor social outcomes.

Methods

Eighty drug users on opioid substitution therapy and 84 demographically matched controls completed measures of mental health and social function. The opioid substitution therapy group were additionally asked to complete a measure that focused on their feelings of stereotype threat in relation to their drug use history. Bivariate correlations and hierarchical regression analyses were conducted to establish the magnitude and specificity of the relationship between stereotype threat and social functioning.

Results

Relative to controls, the opioid substitution therapy group reported higher levels of negative affect and schizotypy, and poorer social functioning, with all three of these indices significantly correlated with their feelings of stereotype threat. The results also showed that stereotype threat contributed significant unique variance to social functioning in the opioid substitution therapy group, even after taking into account other background, clinical, and mental health variables.

Conclusions

Social functioning is an important aspect of recovery, yet these data indicate that people with a history of drug abuse who believe they are the target of stereotypical attitudes have poorer social functioning. This relationship holds after controlling for the impact of other variables on social functioning, including mental health. The theoretical and practical implications of these findings are discussed.

Similar Articles

Personality and the perception of health and happiness

Author(s): Cloninger CR, Zohar AH

J Pers Soc Psychol 54: 1063-1070

Author(s): Watson D, Clark LA, Tellegen A (1988a) Development and validation of brief measures of positive and negative affect: the PANAS scales

Cohort Profile: LifeLines, a three-generation cohort study and biobank

Author(s): Scholtens S, Smidt N, Swertz MA, Bakker SJ, Dotinga A, et al.

Pleasures of the brain

Author(s): Berridge KC

The pleasures of play: pharmacological insights into social reward mechanisms

Author(s): Trezza V, Baarendse PJJ, Vanderschuren LJMJ

The neuro-symphony of stress

Author(s): Joëls M, Baram TZ

Delta Opioid Receptor Signaling Promotes Resilience to Stress Under the Repeated Social Defeat Paradigm in Mice

Author(s): Henry MS, Bisht K, Vernoux N, Gendron L, Torres-Berrio A, et al.

Global Approaches in the Analysis of Cocaine-Induced Gene Expression

Author(s): Eipper-Mains JE, Eipper BA, Mains RE

Nicotine dependence is characterized by disordered reward processing in a network driving motivation

Author(s): Bühler M, Vollstädt-Klein S, Kobiella A, Budde H, Reed LJ, et al.

State-dependent µ-opioid Modulation of Social Motivation–a model

Author(s): Loseth GE, Ellingsen DM, Leknes S

Attacking pain at its source: new perspectives on opioids

Author(s): Stein C, Schafer M, Machelska H

Opioid system and human emotions

Author(s): Nummenmaa L, Tuominen L

Dynorphin, stress, and depression

Author(s): Knoll AT, Carlezon Jr WA

The role of the dynorphin/κ opioid receptor system in anxiety

Author(s): Hang Ai, Wang YJ, He L, Liu JG

Corticolimbic anatomical characteristics predetermine risk for chronic pain

Author(s): Vachon-Presseau E, Tétreault P, Petre B, Huang L, Berger SE, et al.

The Genome of the Netherlands: design, and project goals

Author(s): Boomsma DI, Wijmenga C, Slagboom EP, Swertz MA, Karssen LC, et al.

PLINK: a tool set for whole-genome association and population-based linkage analyses

Author(s): Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al.

Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes

Author(s): Albrechtsen A, Grarup N, Li Y, Sparsø T, Tian G, et al.

J Abnorm Psychol 97: 346-353

Author(s): Watson D, Clark LA, Carey G (1988b) Positive and negative affectivity and their relation to anxiety and depressive disorders

Modeling genetic imprinting effects of DNA sequences with multilocus polymorphism data

Author(s): Wen S1, Wang C, Berg A, Li Y, Chang MM, et al.

Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats

Author(s): Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, et al.

Psychotomimesis mediated by kappa opiate receptors

Author(s): Pfeiffer A, Brantl V, Herz A, Emrich HM

Fast and accurate genotype imputation in genome-wide association studies through pre-phasing

Author(s): Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR